Ulrich Hassiepen

机构：Novartis (Switzerland), Novartis (China)

发表论文 56 篇 · 总被引 3439 次 · h-index 23

代表论文

• Structure of the DDB1–CRBN E3 ubiquitin ligase in complex with thalidomide (2014 · Nature · 被引 1134)
• Crystal structure of the human COP9 signalosome (2014 · Nature · 被引 235)
• Cullin–RING ubiquitin E3 ligase regulation by the COP9 signalosome (2016 · Nature · 被引 225)
• Structural Basis of Ubiquitin Recognition by the Deubiquitinating Protease USP2 (2006 · Structure · 被引 217)
• Targeted inhibition of the COP9 signalosome for treatment of cancer (2016 · Nature Communications · 被引 210)
• Plasma contact system activation drives anaphylaxis in severe mast cell–mediated allergic reactions (2014 · Journal of Allergy and Clinical Immunology · 被引 151)